Nicola Petrosillo

Medicine & Life Sciences

1. Infections 100%
2. HIV 99%
3. Italy 82%
4. Coronavirus 61%
5. Clostridium Infections 55%
6. Communicable Diseases 42%
7. Acinetobacter baumannii 40%
8. Colistin 38%
9. Endocarditis 35%
10. Therapeutics 35%
11. SARS Virus 34%
12. HIV Infections 33%
13. Carbapenems 32%
14. Anti-Bacterial Agents 32%
15. Surgical Wound Infection 32%
16. Intensive Care Units 30%
17. Mortality 30%
18. Pandemics 30%
19. Delivery of Health Care 29%
20. Cross Infection 29%
21. Pulmonary Hypertension 28%
22. Hepacivirus 26%
23. Dialysis 26%
24. Acquired Immunodeficiency Syndrome 24%
25. Methicillin-Resistant Staphylococcus aureus 24%
26. Highly Active Antiretroviral Therapy 24%
27. Ritonavir 24%
28. Occupational Groups 24%
29. Ebola Hemorrhagic Fever 23%
30. Guidelines 23%
31. Infection Control 22%
32. Systematic Reviews 21%
33. Pneumonia 21%
34. Joints 20%
35. Incidence 20%
36. Acinetobacter Infections 20%
37. Epidemiology 20%
38. Virus Diseases 19%
39. Klebsiella pneumoniae 18%
40. Hepatitis B virus 18%
41. Staphylococcal Infections 18%
42. Nuclear Medicine 17%
43. Atazanavir Sulfate 17%
44. Disease Outbreaks 17%
45. Pulmonary Arterial Hypertension 17%
46. Multicenter Studies 16%
47. Clostridium difficile 16%
48. Severe Acute Respiratory Syndrome 16%
49. Microbiology 16%
50. Prospective Studies 16%